Controles
Er is geen wetenschappelijke onderbouwing voor de controlefrequentie. De werkgroep is tot consensus gekomen dat er, uitgaande van het gunstige natuurlijk beloop van mictieklachten, geen reden is om standaard vervolgafspraken te maken bij mannen met milde klachten die niet actief behandeld worden. Het is vanzelfsprekend dat patiënten bij toename van klachten zich weer kunnen melden. Dit beleid is in overeenstemming met de NICE-richtlijn en de NVU-richtlijn. De controle vanwege ingestelde medicamenteuze behandeling vindt (eventueel telefonisch) plaats na zes weken ter beoordeling van het effect en na drie tot zes maanden om met de patiënt te bespreken of de medicatie kan worden gestopt om te beoordelen of de klachten daardoor weer toenemen.
NHG-Standaard Mictieklachten bij mannen - pagina 67
Referenties
Irwin DE, Milsom I, Hunskaar S, Reilly K, Kopp Z, Herschorn S, et al. Population-based survey of urinary incontinence, 1.
overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study. Eur Urol 2006;50:1306-14.
Coyne KS, Matza LS, Kopp ZS, Thompson C, Henry D, Irwin DE, et al. Examining lower urinary tract symptom 2.
constellations using cluster analysis. BJU Int 2008;101:1267-73.
Sexton CC, Coyne KS, Kopp ZS, Irwin DE, Milsom I, Aiyer LP, et al. The overlap of storage, voiding and postmicturition 3.
symptoms and implications for treatment seeking in the USA, UK and Sweden: EpiLUTS. BJU Int 2009;103 Suppl 3:12-23.
Abrams P. New words for old: lower urinary extract symptoms for “prostatism”. Br Med J 1994;308:929. 4.
Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U, et al. The standardisation of terminology in lower 5.
urinary tract function: report from the standardisation sub-committee of the International Continence Society. Urology 2003;61:37-49.
Blanker MH, Groeneveld FP, Bohnen AM, Bernsen RM, Prins A, Thomas S, et al. Voided volumes: normal values and 6.
relation to lower urinary tract symptoms in elderly men, a community-based study. Urology 2001a;57:1093-8. Bosch JL, Hop WC, Kirkels WJ, Schröder FH. The International Prostate Symptom Score in a community-based sample 7.
of men between 55 and 74 years of age: prevalence and correlation of symptoms with age, prostate volume, flow rate and residual urine volume. Br J Urol 1995;75:622-30.
Van Venrooij GE, Boon TA. The value of symptom score, quality of life score, maximal urinary flow rate, residual 8.
volume and prostate size for the diagnosis of obstructive benign prostatic hyperplasia: a urodynamic analysis. J Urol 1996;155:2014-8.
Eckhardt MD, Van Venrooij GE, Boon TA. Symptoms and quality of life versus age, prostate volume, and urodynamic 9.
parameters in 565 strictly selected men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia. Urology 2001;57:695-700.
De La Rosette JJ, Witjes WP, Schafer W, Abrams P, Donovan JL, Peters TJ, et al. Relationships between lower urinary 10.
tract symptoms and bladder outlet obstruction: results from the ICS-”BPH” study. Neurourol Urodyn 1998;17:99-108. Ezz el Din K, Kiemeney LA, De Wildt MJ, Debruyne FM, De La Rosette JJ. Correlation between uroflowmetry, prostate 11.
volume, postvoid residue, and lower urinary tract symptoms as measured by the International Prostate Symptom Score. Urology 1996b;48:393-7.
Van Venrooij GE, Boon TA, De Gier RP. International prostate symptom score and quality of life assessment versus 12.
urodynamic parameters in men with benign prostatic hyperplasia symptoms. J Urol 1995;153:1516-9.
Witjes WP, Aarnink RG, Ezz-el-Din K, Wijkstra H, Debruyne EM, De La Rosette JJ. The correlation between prostate 13.
volume, transition zone volume, transition zone index and clinical and urodynamic investigations in patients with lower urinary tract symptoms. Br J Urol 1997;80:84-90.
Botker-Rasmussen I, Bagi P, Jorgensen JB. Is bladder outlet obstruction normal in elderly men without lower urinary 14.
tract symptoms? Neurourol Urodyn 1999;18:545-51.
Walker RM, Romano G, Davies AH, Theodorou NA, Springall RG, Carter SS. Pressure flow study data in a group of 15.
asymptomatic male control patients 45 years old or older. J Urol 2001;165:683-7.
Chapple CR, Wein AJ, Abrams P, Dmochowski RR, Giuliano F, Kaplan SA, et al. Lower urinary tract symptoms 16.
revisited: a broader clinical perspective. Eur Urol 2008;54:563-9.
Van Doorn B, Kok ET, Blanker MH, Martens EP, Bohnen AM, Bosch JL. The natural history and predictive factors of 17.
voided volume in older men: the Krimpen Study. J Urol 2011b;185:213-8.
Schlatmann TJ. Achtergronden van mictieklachten. In: Van Es JC, Keeman JN, De Leeuw PW, Zitman FG, editors. 18.
Medisch jaarboek 2001. Houten/Diegem: Bohn Stafleu Van Loghum, 2001: 191-6.
Guralnick ML, Grimsby G, Liss M, Szabo A, O’Connor RC. Objective differences between overactive bladder patients 19.
with and without urodynamically proven detrusor overactivity. Int Urogynecol J 2010;21:325-9.
Coyne KS, Sexton CC, Vats V, Thompson C, Kopp ZS, Milsom I. National community prevalence of overactive bladder 20.
in the United States stratified by sex and age. Urology 2011;77:1081-7.
Cheung WW, Blank W, Borawski D, Tran W, Bluth MH. Prevalence of overactive bladder, its under-diagnosis, and risk 21.
factors in a male urologic veterans population. Int J Med Sci 2010;7:391-4.
Homma Y, Kakizaki H, Yamaguchi O, Yamanishi T, Nishizawa O, Yokoyama O, et al. Assessment of overactive bladder 22.
symptoms: comparison of 3-day bladder diary and the overactive bladder symptoms score. Urology 2011;77:60-4. Kaplan SA, Wein AJ, Staskin DR, Roehrborn CG, Steers WD. Urinary retention and post-void residual urine in men: 23.
separating truth from tradition. J Urol 2008;180:47-54.
NVU. Bacteriële urineweginfecties bij adolescenten en volwassenen. Etiologie, diagnostiek, behandeling en profylaxe 24.
(2009). Nederlandse Vereniging voor Urologie. Ga naar bron: NVU. Bacteriële urineweginfecties bij adolescenten en volwassenen. Etiologie, diagnostiek, behandeling en profylaxe (2009). Nederlandse Vereniging voor Urologie.
Tikkinen KA, Johnson TM, Tammela TL, Sintonen H, Haukka J, Huhtala H, et al. Nocturia frequency, bother, and 25.
Blanker MH, Bernsen RM, Bosch JL, Thomas S, Groeneveld FP, Prins A, et al. Normal values and determinants of 26.
circadian urine production in older men: a population based study. J Urol 2002a;168:1453-7.
Van Doorn B, Blanker MH, Kok ET, Westers P, Bosch JL. Prevalence, incidence and resolution of nocturnal polyuria in 27.
a longitudinal community-based study in older men: the Krimpen study. Eur Urol 2013;63:542-7.
Van Kerrebroeck P, Abrams P, Chaikin D, Donovan J, Fonda D, Jackson S, et al. The standardisation of terminology in 28.
nocturia: report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn 2002;21:179-83.
Van Haarst, EP, Bosch JL. A cutoff value based on analysis of a reference population decreases overestimation of the 29.
prevalence of nocturnal polyuria. J Urol 2012b;188:869-73.
Blanker MH, Groeneveld FP, Prins A, Bernsen RM, Bohnen AM, Bosch JL. Strong effects of definition and nonresponse 30.
bias on prevalence rates of clinical benign prostatic hyperplasia: the Krimpen study of male urogenital tract problems and general health status. BJU Int 2000a;85:665-71.
Wolters R, Wensing M, Van Weel C, Van der Wilt GJ, Grol RP. Lower urinary tract symptoms: social influence is more 31.
important than symptoms in seeking medical care. BJU Int 2002;90:655-61.
Sonke GS, Kolman D, De La Rosette JJ, Donkers LHC, Boyle P, Kiemeney LALM. Prevalentie van lagere-32.
urinewegsymptomen bij mannen en de invloed op hun kwaliteit van leven: Het Boxmeer-onderzoek. Ned Tijdschr Geneeskd 2000;144:2558-63.
Wolfs GG, Knottnerus JA, Van der Horst FG, Visser AP, Janknegt RA. Determinants of doctor consultation for 33.
micturition problems in an elderly male population. Eur Urol 1998;33:1-10.
Kok ET, Bohnen AM, Groeneveld FP, Busschbach JJ, Blanker MH, Bosch JL. Changes in disease specific and generic 34.
quality of life related to changes in lower urinary tract symptoms: the Krimpen study. J Urol 2005;174:1055-8. Sarma AV, Jacobsen SJ, Girman CJ, Jacobson DJ, Roberts RO, Rhodes T, et al. Concomitant longitudinal changes in 35.
frequency of and bother from lower urinary tract symptoms in community dwelling men. J Urol 2002;168:1446-52. Parsons JK, Wilt TJ, Wang PY, Barrett-Connor E, Bauer DC, Marshall LM. Progression of lower urinary tract symptoms 36.
in older men: a community based study. J Urol 2010;183:1915-20.
Thom D. Variation in estimates of urinary incontinence prevalence in the community: effects of differences in 37.
definition, population characteristics, and study type. J Am Geriatr Soc 1998;46:473-80. ICS. Incontinence. 4th ed. Parijs: International Consultation on Incontinence, 2009. 38.
Herzog AR, Diokno AC, Brown MB, Normolle DP, Brock BM. Two-year incidence, remission, and change patterns of 39.
urinary incontinence in noninstitutionalized older adults. J Gerontol 1990;45:M67-M74.
McGrother CW, Donaldson MM, Shaw C, Matthews RJ, Hayward TA, Dallosso HM, et al. Storage symptoms of the 40.
bladder: prevalence, incidence and need for services in the UK. BJU Int 2004;93:763-9.
Abrams P, Klevmark B. Frequency volume charts: an indispensable part of lower urinary tract assessment. Scand J 41.
Urol Nephrol Suppl 1996;179:47-53.
Boyle P, Robertson C, Mazzetta C, Keech M, Hobbs FD, Fourcade R, et al. The prevalence of lower urinary tract 42.
symptoms in men and women in four centres. The UrEpik study. BJU Int 2003a;92:409-14.
Boyle P, Robertson C, Mazzetta C, Keech M, Hobbs FD, Fourcade R, et al. The prevalence of male urinary incontinence 43.
in four centres: the UREPIK study. BJU Int 2003b;92:943-7.
Kupelian V, Wei JT, O‘Leary MP, Kusek JW, Litman HJ, Link CL et al. Prevalence of lower urinary tract symptoms and 44.
effect on quality of life in a racially and ethnically diverse random sample: the Boston Area Community Health (BACH) Survey. Arch Intern Med 2006;166:2381-7.
Roberts RO, Rhodes T, Panser LA, Girman CJ, Chute CG, Oesterling JE, et al. Natural history of prostatism: worry and 45.
embarrassment from urinary symptoms and health care-seeking behavior. Urology 1994;43:621-8.
Andersson SO, RashidKhani B, Karlberg L, Wolk A, Johansson JE. Prevalence of lower urinary tract symptoms in men 46.
aged 45-79 years: a population-based study of 40 000 Swedish men. BJU Int 2004;94:327-31.
Seim A, Hoyo C, Ostbye T, Vatten L. The prevalence and correlates of urinary tract symptoms in Norwegian men: the 47.
HUNT study. BJU Int 2005;96:88-92.
Joseph MA, Harlow SD, Wei JT, Sarma AV, Dunn RL, Taylor JM, et al. Risk factors for lower urinary tract symptoms in 48.
a population-based sample of African-American men. Am J Epidemiol 2003;157:906-14.
Kristal AR, Arnold KB, Schenk JM, Neuhouser ML, Weiss N, Goodman P, et al. Race/ethnicity, obesity, health related 49.
behaviors and the risk of symptomatic benign prostatic hyperplasia: results from the prostate cancer prevention trial. J Urol 2007;177:1395-400.
Taylor J, McGrother CW, Harrison SC, Assassa PR. Lower urinary tract symptoms and related help-seeking behaviour 50.
in South Asian men living in the UK. BJU Int 2006;98:605-9.
Wolfs GG, Knottnerus JA, Janknegt RA. Prevalence and detection of micturition problems among 2,734 elderly men. J 51.
Urol 1994;152:1467-70.
Van de Lisdonk EH. Ervaren en aangeboden morbiditeit in de huisartspraktijk. Een onderzoek met dagboeken 52.
[dissertatie]. Nijmegen: Katholieke Universiteit, 1985.
Van der Heide WK. Mannen met plasklachten in de huisartspraktijk [proefschrift]. Groningen: Rijksuniversiteit 53.
Groningen, 2006.
Cunningham-Burley S, Allbutt H, Garraway WM, Lee AJ, Russell EB. Perceptions of urinary symptoms and health-care-54.
NHG-Standaard Mictieklachten bij mannen - pagina 69
seeking behaviour amongst men aged 40-79 years. Br J Gen Pract 1996;46:349-52.
Sprangers MA, Schwartz CE. Integrating response shift into health-related quality of life research: a theoretical model. 55.
Soc Sci Med 1999;48:1507-15.
Garraway WM, Russell EB, Lee RJ, Collins GN, McKelvie GB, Hehir M, et al. Impact of previously unrecognized benign 56.
prostatic hyperplasia on the daily activities of middle-aged and elderly men. Br J Gen Pract 1993;43:318-21. Sladden MJ, Hughes AM, Hirst GH, Ward JE. A community study of lower urinary tract symptoms in older men in 57.
Sydney, Australia. Aust N Z J Surg 2000;70:322-8.
Teunissen TA, Lagro-Janssen AL. Sex differences in the use of absorbent (incontinence) pads in independently living 58.
elderly people: do men receive less care? Int J Clin Parct 2009;63:869-73.
Van der Linden MW, Westert GP, De Bakker DH, Schellevis FG. Tweede Nationale Studie naar ziekten en 59.
verrichtingen in de huisartspraktijk. Kernrapport I: klachten en aandoeningen in de bevolking en in de huisartspraktijk. Utrecht/Bilthoven: NIVEL/RIVM, 2004.
Van de Lisdonk EH, Van den Bosch WJHM, Lagro-Janssen ALM. Ziekten in de huisartspraktijk. 5e druk. Maarssen: 60.
Elsevier Gezondheidszorg, 2008.
Tubaro A, La Vecchia C; Uroscreening Study Group. The relation of lower urinary tract symptoms with life-style 61.
factors and objective measures of benign prostatic enlargement and obstruction: an Italian survey. Eur Urol 2004;45:767-72.
Gass R. Benign prostatic hyperplasia: the opposite effects of alcohol and coffee intake. BJU Int 2002;90:649-54. 62.
Prezioso D, Catuogno C, Galassi P, D’Andrea G, Castello G, Pirritano D. Life-style in patients with LUTS suggestive of 63.
BPH. Eur Urol 2001;40 Suppl 1:9-12.
Parsons JK, Im R. Alcohol consumption is associated with a decreased risk of benign prostatic hyperplasia. J Urol 64.
2009;182:1463-8.
Matzkin H, Soloway MS. Cigarette smoking: a review of possible associations with benign prostatic hyperplasia and 65.
prostate cancer. Prostate 1993;22:277-90.
Laven BA, Orsini N, Andersson SO, Johansson JE, Gerber GS, Wolk A. Birth weight, abdominal obesity and the risk of 66.
lower urinary tract symptoms in a population based study of Swedish men. J Urol 2008;179:1891-5.
Parsons JK, Carter HB, Partin AW, Windham BG, Metter EJ, Ferrucci L, et al. Metabolic factors associated with benign 67.
prostatic hyperplasia. J Clin Endocrinol Metab 2006;91:2562-8.
Kok ET, Bohnen AM, Bosch JL, Thomas S, Groeneveld FP, Patient’s quality of life and coping style influence general 68.
practitioner’s management in men with lower urinary tract symptoms: the Krimpen study. Qual Life Res 2006;15:1335-43.
Sarma AV, Wei JT, Jacobson DJ, Dunn RL, Roberts RO, Girman CJ, et al. Comparison of lower urinary tract symptom 69.
severity and associated bother between community-dwelling black and white men: the Olmsted County Study of Urinary Symptoms and Health Status and the Flint Men’s Health Study. Urology 2003;61:1086-91.
Van Doorn B, Blanker MH, Kok ET, Westers P, Bosch JL. Once nocturia, always nocturia? Natural history of nocturia in 70.
older men based on frequency-volume charts: the Krimpen study. J Urol 2011a;186:1956-61.
Temml C, Brossner C, Schatzl G, Ponholzer A, Knoepp L, Madersbacher S. The natural history of lower urinary tract 71.
symptoms over five years. Eur Urol 2003;43:374-80.
Blanker MH, Bohnen AM, Groeneveld FP, Bernsen RM, Prins A, Bosch JL. Normal voiding patterns and determinants 72.
of increased diurnal and nocturnal voiding frequency in elderly men. J Urol 2000b;164:1201-5.
Blanker MH, Prins J, Bohnen AM, Thomas S, Bosch JL. De waarde van het plasdagboek bij oudere mannen met 73.
plasklachten. Huisarts Wet 2003;46:243-7.
Meigs JB, Barry MJ, Giovannucci E, Rimm EB, Stampfer MJ, Kawachi I. Incidence rates and risk factors for acute 74.
urinary retention: the health professionals followup study. J Urol 1999;162:376-82.
Ponholzer A, Temml C, Obermayr RP, Rauchenwald M, Madersbacher S. The association between lower urinary tract 75.
symptoms and renal function in men: a cross-sectional and 5-year longitudinal analysis. J Urol 2006;175:1398-402. Hallan SI, Kwong D, Vikse BE, Stevens P. Use of a prostate symptom score to identify men at risk of future kidney 76.
failure: insights from the HUNT II Study. Am J Kidney Dis 2010;56:477-85.
Hong SK, Lee ST, Jeong SJ, Byun SS, Hong YK, Park DS, et al. Chronic kidney disease among men with lower urinary 77.
tract symptoms due to benign prostatic hyperplasia. BJU Int 2010;105:1424-8.
Van Haarst, EP, Bosch JL, Heldeweg EA. The international prostate symptom score overestimates nocturia assessed by 78.
frequency-volume charts. J Urol 2012a;188:211-215.
Averbeck MA, Madersbacher H. Constipation and LUTS - how do they affect each other? Int Braz J Urol 79.
2011;37:16-28.
Charach G, Greenstein A, Rabinovich P, Groskopf I, Weintraub M. Alleviating constipation in the elderly improves 80.
lower urinary tract symptoms. Gerontology 2001;47:72-6.
CBS. Permanent Onderzoek LeefSituatie (POLS) (2011). Ga naar bron: CBS. Permanent Onderzoek LeefSituatie
81.
(POLS) (2011).
Brown CT, O’Flynn E, Van der Meulen J, Newman S, Mundy AR, Emberton M. The fear of prostate cancer in men with 82.
lower urinary tract symptoms: should symptomatic men be screened? BJU Int 2003;91:30-2.
Blanker MH, Bohnen AM, Groeneveld FP, Bernsen RM, Prins A, Thomas S , et al. Correlates for erectile and 83.
ejaculatory dysfunction in older Dutch men: a community-based study. J Am Geriatr Soc 2001b;49:436-42. Weatherall M, Harwood M. The accuracy of clinical assessment of bladder volume. Arch Phys Med Rehabil 84.
2002;83:1300-2.
Bosch JL, Bohnen AM, Groeneveld FP. Validity of digital rectal examination and serum prostate specific antigen in the 85.
estimation of prostate volume in community-based men aged 50 to 78 years: the Krimpen Study. Eur Urol 2004;46:753-9.
NVU. Diagnostiek en behandeling van LUTS/BPH (2005). Nederlandse Vereniging voor Urologie. Ga naar bron: NVU.
86.
Diagnostiek en behandeling van LUTS/BPH (2005). Nederlandse Vereniging voor Urologie.
Lepor H, Machi G. Comparison of AUA symptom index in unselected males and females between fifty-five and seventy-87.
nine years of age. Urology 1993;42:36-40.
Chai TC, Belville WD, McGuire EJ, Nyquist L. Specificity of the American Urological Association voiding symptom 88.
index: comparison of unselected and selected samples of both sexes. J Urol 1993;150:1710-3.
Gisolf KW, Van Venrooij GE, Eckhardt MD, Boon TA. Analysis and reliability of data from 24-hour frequency-volume 89.
charts in men with lower urinary tract symptoms due to benign prostatic hyperplasia. Eur Urol 2000;38:45-52. Meiland R, Geerlings SE, Hoes AW, Hoepelman IM. Asymptomatische bacteriurie; beleidskeuzen in verschillende 90.
patiëntengroepen. Ned Tijdschr Geneeskd 2002;146:659-62.
Nicolle LE. Asymptomatic bacteriuria in the elderly. Infect Dis Clin North Am 1997;11:647-62. 91.
Ezz el Din K, Koch WF, De Wildt MJ, Debruyne FM, De La Rosette JJ. The predictive value of microscopic haematuria 92.
in patients with lower urinary tract symptoms and benign prostatic hyperplasia. Eur Urol 1996a;30:409-13. Jones R, Latinovic R, Charlton J, Gulliford MC. Alarm symptoms in early diagnosis of cancer in primary care: cohort 93.
study using General Practice Research Database. BMJ 2007;334:1040.
Jones R, Charlton J, Latinovic R, Gulliford MC. Alarm symptoms and identification of non-cancer diagnoses in primary 94.
care: cohort study. BMJ 2009;339:b3094.
Chan ES, Ng CF, Hou SM, Yip SK. Using urine microscopy and cytology for early detection of bladder cancer in male 95.
patients with lower urinary tract symptoms. Int Urol Nephrol 2011;43:289-94.
Khadra MH, Pickard RS, Charlton M, Powell PH, Neal DE. A prospective analysis of 1,930 patients with hematuria to 96.
evaluate current diagnostic practice. J Urol 2000;163:524-7.
Boman H, Hedelin H, Holmang S. The results of routine evaluation of adult patients with haematuria analysed 97.
according to referral form information with 2-year follow-up. Scand J Urol Nephrol 2001;35:497-501.
Rodgers M, Nixon J, Hempel S, Aho T, Kelly J. Neal D, et al. Diagnostic tests and algorithmes used in the investigation 98.
of haematuria: systematic reviews and economic evaluation. Health Technol Asess 2006;10:iii-iv,xi-259. Zackrisson B, Ulleryd P, Aus G, Lilja H, Sandberg T, Hugosson J. Evolution of free, complexed, and total serum 99.
prostate-specific antigen and their ratios during 1 year of follow-up of men with febrile urinary tract infection. Urology 2003;62:278-81.
Bohnen AM, Groeneveld FP, Bosch JL. Serum prostate-specific antigen as a predictor of prostate volume in the 100.
community: the Krimpen study. Eur Urol 2007;51:1645-52.
NICE. The management of lower urinary tract symptoms in men. Londen: National Clinical Guideline Centre, 2010. 101.
Wasserman NF, Lapointe S, Eckmann DR, Rosel PR. Assessment of prostatism: role of intravenous urography. 102.
Radiology 1987;165:831-5.
Patel NS, Blick C, Kumar PV, Malone PR. The diagnostic value of abdominal ultrasound, urine cytology and prostate-103.
specific antigen testing in the lower urinary tract symptoms clinic. Int J Clin Pract 2009;63:1734-8.
Krieger JN, Nyberg L, Jr., Nickel JC. NIH consensus definition and classification of prostatitis. JAMA 1999;282:236-7. 104.
Mundy AR, Andrich DE. Urethral strictures. BJU Int 2011;107:6-26. 105.
Wolters R, Wensing M, Van Weel C, Grol R. The effect of a distance-learning programme on patient self-management 106.
of Lower Urinary Tract Symptoms (LUTS) in general practice: a randomised controlled trial. Eur Urol 2004;46:95-101. Parsons JK, Kashefi C. Physical activity, benign prostatic hyperplasia, and lower urinary tract symptoms. Eur Urol 107.
2008;53:1228-35.
Parsons JK, Messer K, White M, Barrett-Connor E, Bauer DC, Marshall LM. Obesity increases and physical activity 108.
decreases lower urinary tract symptom risk in older men: the Osteoporotic Fractures in Men study. Eur Urol 2011;60:1173-80.
Norg RJ. A general practitioner’s approach to lower urinary tract symptoms [PhD thesis], University Maastricht, 2008. 109.
Burgio KL, Goode PS, Johnson TM, Hammontree L, Ouslander JG, Markland AD, et al. Behavioral versus drug 110.
treatment for overactive bladder in men: the Male Overactive Bladder Treatment in Veterans (MOTIVE) Trial. J Am Geriatr Soc 2011;59:2209-16.
Paterson J, Pinnock CB, Marshall VR. Pelvic floor exercises as a treatment for post-micturition dribble. Br J Urol 111.
1997;79:892-7.
Shafik A, Shafik IA. Overactive bladder inhibition in response to pelvic floor muscle exercises. World J Urol 112.
2003;20:374-7.
Dumoulin C, Hay-Smith J. Pelvic floor muscle training versus no treatment, or inactive control treatments, for urinary 113.
incontinence in women. Cochrane Database Syst Rev 2010;CD005654.
Campbell SE, Glazener CM, Hunter KF, Cody JD, Moore KN. Conservative management for postprostatectomy urinary 114.
NHG-Standaard Mictieklachten bij mannen - pagina 71
incontinence. Cochrane Database Syst Rev 2012;1:CD001843.